| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/24/2002 | US20020009432 Promoter for chondrocyte proliferation agent; administering hepatocyte growth factor |
| 01/24/2002 | US20020009431 Method for transplanting cells into the brain and therapeutic uses therefor |
| 01/24/2002 | US20020009428 Combination therapy for cancer |
| 01/24/2002 | US20020009427 Methods of therapy for non-hodgkin's lymphoma |
| 01/24/2002 | US20020009417 Nucleosome-based anti-tumor compositions |
| 01/24/2002 | DE10126344A1 Apoptose-induzierende DNA-Sequenzen Apoptosis-inducing DNA sequences |
| 01/24/2002 | DE10033245A1 Verwendungen des Hitzeschockproteins gp96 Uses of the heat shock protein gp96 |
| 01/24/2002 | DE10033219A1 Use of granulocyte colony stimulating factor as neuroprotective agent, for treating acute ischemia and neurodegenerative diseases |
| 01/24/2002 | DE10030466A1 Nukleotid- und Aminosäurensequenzen eines zellulären Repressors der DNA Replikation des Herpesvirus Epstein-Barr Nucleotide and amino acid sequences of a cellular repressor of DNA replication of the herpes virus Epstein-Barr |
| 01/24/2002 | DE10030376A1 Treating DNA with enzyme that alters sensitivity to exonuclease, useful e.g. for identifying therapeutic inhibitors of the enzyme |
| 01/24/2002 | CA2450747A1 Derivatives of laspartomycin and preparation and use thereof |
| 01/24/2002 | CA2450372A1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| 01/24/2002 | CA2418391A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | CA2418214A1 Antimicrobial agent |
| 01/24/2002 | CA2418146A1 Use of matrix metalloprotease inhibitors for the treatment of cancer |
| 01/24/2002 | CA2416986A1 Crf2 ligands in combination therapy |
| 01/24/2002 | CA2416813A1 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis |
| 01/24/2002 | CA2416693A1 Phosphatonin-related gene and methods of use thereof |
| 01/24/2002 | CA2416487A1 Stimulation of bone growth with thrombin peptide derivatives |
| 01/24/2002 | CA2416452A1 Novel proteins and nucleic acids encoding same |
| 01/24/2002 | CA2416445A1 Human rrp sequences and methods of use |
| 01/24/2002 | CA2416285A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/24/2002 | CA2416153A1 Mutant rad51 paralog genes and use thereof in anticancer therapy |
| 01/24/2002 | CA2416004A1 Method for encapsulating fine solid particles in the form of microcapsules |
| 01/24/2002 | CA2415938A1 Alpha-msh related compounds and methods of use |
| 01/24/2002 | CA2415751A1 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | CA2415723A1 Methylated nucleotide regulation of upa gene expression |
| 01/24/2002 | CA2415712A1 Protein complex serving as a vehicle for orally administerable medicaments |
| 01/24/2002 | CA2415701A1 Compositions and methods for the treatment of skin damage |
| 01/24/2002 | CA2415690A1 Tetraspan protein and uses thereof |
| 01/24/2002 | CA2415557A1 Compounds for the treatment of sexual dysfunction |
| 01/24/2002 | CA2415481A1 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 01/24/2002 | CA2415325A1 Preventing airway mucus production by administration of egf-r antagonists |
| 01/24/2002 | CA2415285A1 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds |
| 01/24/2002 | CA2415202A1 Extracellular matrix protein |
| 01/24/2002 | CA2415128A1 An implantable or insertable therapeutic agent delivery device |
| 01/23/2002 | EP1174506A1 C-terminal Erns peptide and analogues thereof |
| 01/23/2002 | EP1174505A1 (Poly)peptides for the preparation of vaccines against Bordetella pertussis and/or Bordetella parapertussis, vaccines based upon such (poly)peptides, and antibodies against such peptides |
| 01/23/2002 | EP1174504A1 Apoptosis-associated gene |
| 01/23/2002 | EP1174501A1 Gene expression base sequences for therapeutic use and drugs for gene therapy |
| 01/23/2002 | EP1174438A1 Novel cyclic tetrapeptide derivatives and use thereof as drugs |
| 01/23/2002 | EP1174437A1 Melanocyte-stimulating hormone inhibitors |
| 01/23/2002 | EP1174149A1 Proliferation inhibitor for androgen-independent tumor |
| 01/23/2002 | EP1174147A1 Reversal of antibiotic resistance with lysozyme dimer |
| 01/23/2002 | EP1174146A1 Agents for ameliorating pancreatic function disorder |
| 01/23/2002 | EP1174143A1 Green tea extract and use thereof in treating renal dysfunction induced by cyclosporins or ascomycins |
| 01/23/2002 | EP1174142A2 Immunopotentiator comprising peptide and hyaluronic acid |
| 01/23/2002 | EP1174129A1 Use of a matrix-metalloprotease inhibitor for the treatment of cancer |
| 01/23/2002 | EP1173768A1 Methods of diagnosing or treating depression |
| 01/23/2002 | EP1173767A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/23/2002 | EP1173764A1 Method for identifying an individual at risk for irreversible neurodamages, comprising the steps of determining quantitatively the concentration of pepsinogen i (pgi) and vitamin b12 |
| 01/23/2002 | EP1173614A1 Antisense oligonucleotides comprising universal and/or degenerate bases |
| 01/23/2002 | EP1173608A1 Interaction of vascular-endothelial protein-tyrosine phosphatase with the angiopoietin receptor tie-2 |
| 01/23/2002 | EP1173600A2 Cationic peg-lipids and methods of use |
| 01/23/2002 | EP1173590A2 Zymogen activation system |
| 01/23/2002 | EP1173571A2 Human ion channel proteins |
| 01/23/2002 | EP1173569A1 Synthetic signalling molecules |
| 01/23/2002 | EP1173568A2 Laminin 2 and methods for its use |
| 01/23/2002 | EP1173567A2 Tribonectins |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173565A1 Adipocyte complement related protein homolog zacrp3 |
| 01/23/2002 | EP1173564A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension |
| 01/23/2002 | EP1173562A2 Inhibition of histone deacetylase |
| 01/23/2002 | EP1173561A2 Non-invasive method for detecting target rna |
| 01/23/2002 | EP1173560A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2002 | EP1173552A2 Carbohydrate-modifying enzymes |
| 01/23/2002 | EP1173484A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 01/23/2002 | EP1173482A1 Insulin crystals for pulmonary administration |
| 01/23/2002 | EP1173481A1 Inactivated cytokines for immunisation |
| 01/23/2002 | EP1173480A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 01/23/2002 | EP1173479A1 49 human secreted proteins |
| 01/23/2002 | EP1173478A1 49 human secreted proteins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173476A1 Soybean protein nutraceuticals |
| 01/23/2002 | EP1173475A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 01/23/2002 | EP1173474A1 Membrane disruptive peptides covalently oligomerized |
| 01/23/2002 | EP1173473A1 Antifungal agents isolated from pseudomonas syringae |
| 01/23/2002 | EP1173472A1 Cyclic hexapeptides having antibiotic activity |
| 01/23/2002 | EP1173471A2 Pseudomycin analogs |
| 01/23/2002 | EP1173470A1 Treatment of bone disorders with adrenomedullin or adrenomedullin agonists |
| 01/23/2002 | EP1173469A2 Adhesion modulatory peptides and methods for use |
| 01/23/2002 | EP1173468A1 Integrin receptor antagonists |
| 01/23/2002 | EP1173467A1 Chemokine-derived synthetic peptides |
| 01/23/2002 | EP1173466A1 Method of inhibiting leukocyte adhesion to fibrinogen |
| 01/23/2002 | EP1173462A1 50 human secreted proteins |
| 01/23/2002 | EP1173461A1 50 human secreted proteins |
| 01/23/2002 | EP1173458A1 Antisense modulation of sra expression |
| 01/23/2002 | EP1173457A1 Polynucleotide and polypeptide sequences encoding human organic anion transporter 6(hoatp6) and screening methods thereof |
| 01/23/2002 | EP1173456A1 Secreted proteins and nucleic acids encoding them |
| 01/23/2002 | EP1173414A1 N-protected amines and their use as prodrugs |
| 01/23/2002 | EP1173413A1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 01/23/2002 | EP1173225A2 Agent for gene therapy and for the prevention of metastases, as well as for the gene therapy of tumors |
| 01/23/2002 | EP1173224A1 Polyethyleneimine:dna formulations for aerosol delivery |
| 01/23/2002 | EP1173223A2 Conjugates as therapies for cancers and prostate diseases |
| 01/23/2002 | EP1173222A2 Conjugate having a cleavable linkage for use in a liposome |
| 01/23/2002 | EP1173221A2 Releasable linkage and compositions containing same |
| 01/23/2002 | EP1173204A1 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/23/2002 | EP1173200A1 Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins |
| 01/23/2002 | EP1173199A1 RAS ONCOGEN p21 PEPTIDE VACCINES |
| 01/23/2002 | EP1173198A2 Biochemical methods that eliminate corneal scars, opacification and haze |